You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial

Article metrics

Article menu

Download PDFPDF

XML
Rheumatology
Protocol
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019477468105
Jan 202025124784
Feb 202019619164
Mar 202014314042
May 2020797430
Jun 2020504829
Jul 2020757328
Aug 2020736729
Sep 2020625723
Oct 2020858525
Nov 2020706427
Dec 2020736742
Jan 2021585834
Feb 2021626130
Mar 2021656129
Apr 2021575339
May 2021757334
Jun 202112011860
Jul 2021696044
Aug 2021696250
Sep 20219284173
Oct 2021918155
Nov 202111610268
Dec 2021766635
Jan 2022656443
Feb 2022534327
Mar 2022655930
Apr 2022494723
May 2022646042
Jun 2022786935
Jul 2022272717
Aug 2022383528
Sep 2022676640
Oct 2022534344
Nov 2022534624
Dec 2022514818
Jan 2023686029
Feb 2023484324
Mar 2023654929
Apr 2023403433
May 2023595235
Jun 2023705331
Jul 2023353112
Aug 2023747032
Sep 202311410918
Oct 2023443823
Nov 2023514616
Dec 2023645615
Jan 2024603617
Feb 2024484329
Mar 2024504056
Apr 2024434330
May 2024626134
Jun 2024504740
Jul 2024646234
Aug 2024597833
Sep 2024625739
Oct 202410106
Total448741852165